Consultation on Guidance on Change Management Program (CMP) for SaMD
The Medical Devices Cluster (MDC) has released a draft of Guidance on Change Management Program (CMP) for SaMD for stakeholders' consultation. The document describes the regulatory requirements and procedures for CMP submission. CMP is a new optional regulatory pathway specifically for SaMD that is incorporated into HSA's Premarket Product Registration and Change Notification (CN) processes, which also introduces the concept of Pre-specified changes.
We would like to invite our stakeholders to provide feedback on the Guidance on Change Management Program (CMP) for SaMD:
Guidance on Change Management Program for SaMD_For consultation
The Consultation period for this document is from 26 August 2024 to 21 October 2024. Please email your feedback using the prescribed feedback form to HSA_MD_INFO@hsa.gov.sg by 21 October 2024 and with "Feedback on Guidance on CMP for SaMD" in the email subject header.
Consultation feedback form - Guidance on CMP for SaMD
Briefing webinar slides: Industry Briefing on CMP for SaMD_slides
Industry member, Medical devices
Published:
Regulatory Updates